How do you manage a patient suspected of having a pulmonary embolism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ruling Out Pulmonary Embolism: A Practical Approach

To rule out PE, you need the absence of all three key clinical features: tachypnea (>20/min), pleuritic chest pain, and arterial hypoxemia—if all three are absent, PE can be excluded. 1

Clinical Assessment and Risk Stratification

Record the respiratory rate in every patient with suspected PE, as this is a critical discriminating feature that is often overlooked. 1 The presence of unexplained acute dyspnea, hypoxemia, and a normal chest radiograph should trigger immediate investigation for PE. 1

Key Risk Factors to Identify

Predisposing factors are present in 80-90% of PE cases. 1 The most common include:

  • Recent immobilization >1 week 1
  • Previous DVT or PE 1
  • Recent major surgery 1
  • Lower limb fractures or surgery 1
  • Active malignancy 1
  • Pregnancy or postpartum state 1

Important caveat: Young women whose only risk factor is oral contraception who present with isolated pleuritic chest pain are very unlikely to have PE if respiratory rate is <20/min and chest radiograph is normal. 1

Initial Diagnostic Workup

Perform these tests immediately in all patients with suspected PE:

  • Chest radiography 1
  • ECG 1
  • Arterial blood gas measurements 1
  • Respiratory rate documentation 1

D-Dimer Testing

Normal D-dimer levels exclude PE in patients with low to intermediate clinical probability. 1, 2 However, the laboratory must offer a reliable D-dimer assay for this exclusion strategy to be valid. 1

Imaging Strategy

CT Pulmonary Angiography (CTPA)

Proceed to CTPA for patients with high clinical probability or elevated D-dimer. 2 This should be performed within 24 hours of clinical suspicion. 1

Critical pitfall: If CTPA reports single subsegmental PE, consider false-positive findings and discuss with radiology for a second opinion before committing to anticoagulation. 2 Subsegmental emboli are often missed and their clinical significance remains debated. 1

Lung Scanning Considerations

Isotope lung scanning is not recommended if: 1

  • Unavailable on-site
  • Patient has chronic cardiac or respiratory disease
  • Chest radiograph is abnormal

When lung scanning is performed, ventilation should be assessed by technetium-labeled aerosol rather than 133Xe. 1 Requests must be accompanied by an estimate of clinical probability. 1

Interpreting Scan Results:

  • Normal scan = no PE 1
  • Scan + clinical probability both low = no PE 1
  • Scan + clinical probability both high = PE present 1
  • Any other combination = needs CTPA 1

Alternative: Leg Vein Imaging

Leg ultrasound is an alternative to lung imaging in patients with clinical DVT. 1 This should be the first-line investigation for suspected PE in patients with previous PE, clinical DVT, or chronic cardiorespiratory disease. 1

When PE Cannot Be Excluded

For patients with indeterminate results, further imaging is required rather than management based on clinical features alone. 1 In high clinical probability cases with negative CTPA, valid alternatives include: 1

  • Concluding PE has been excluded and stopping heparin
  • Considering further imaging for VTE (leg ultrasound, conventional pulmonary angiography)
  • Seeking specialist advice

Pulmonary angiography should be considered when other investigations fail to confirm the diagnosis. 1

Immediate Anticoagulation Decision

Start anticoagulation immediately when PE is suspected based on clinical probability, even before diagnostic confirmation is complete, unless active bleeding or absolute contraindications exist. 2 Heparin should be initiated on the basis of high or intermediate clinical suspicion before the diagnosis is clarified. 1

Heparin Dosing

Weight-adjusted heparin: Initial bolus of 80 IU/kg IV, followed by continuous infusion of 18 IU/kg/hour, targeting aPTT 1.5-2.5 times control (45-75 seconds). 2, 1 3

Monitor aPTT: 1

  • 4-6 hours after initial bolus
  • 6-10 hours after any dose change
  • Daily once in therapeutic range

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Approach to Pulmonary Embolism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.